Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Pathologic Complete Response, Head and Neck Neoplasms

Esophageal Squamous Cell Carcinoma

Pancreatic cancer, adult

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Nasopharyngeal Carcinoma

Pancreatic cancer, adult

Nasopharyngeal Carcinoma

Uterine Cervical Neoplasms

Lung Neoplasms

Pancreatic Cancer Resectable

Esophageal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Advanced Pancreatic Cancer

Esophageal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Diffuse Intrinsic Pontine Glioma

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Penile Neoplasms

Adenoma, Islet Cell

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Lung Neoplasms, Meningeal Carcinomatosis

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Nasopharyngeal Carcinoma

Childhood Brain Stem Neoplasm

Nasopharyngeal Carcinoma, Recurrence

Clinical Trials

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

PIONEER-HN

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

NOTABLE-309

HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients

Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma

AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer

Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma

CC11

Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Nim-PC-28

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study

Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

DIPG

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

GCR-05

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

TRUMP

TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Carpp-1

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer

Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC

Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma